TR201906738T4 - Bir çekirdek ve bir kılıf içeren kontrasepsiyonda kullanıma yönelik ilaç taşıyıcı sistem. - Google Patents

Bir çekirdek ve bir kılıf içeren kontrasepsiyonda kullanıma yönelik ilaç taşıyıcı sistem. Download PDF

Info

Publication number
TR201906738T4
TR201906738T4 TR2019/06738T TR201906738T TR201906738T4 TR 201906738 T4 TR201906738 T4 TR 201906738T4 TR 2019/06738 T TR2019/06738 T TR 2019/06738T TR 201906738 T TR201906738 T TR 201906738T TR 201906738 T4 TR201906738 T4 TR 201906738T4
Authority
TR
Turkey
Prior art keywords
sheath
core
delivery system
drug delivery
contraception
Prior art date
Application number
TR2019/06738T
Other languages
English (en)
Inventor
Loxley Andrew
Mitchnick Mark
Hernández Herrero Gonzalo
Ronchi Celestino
Original Assignee
Chemo Res S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Res S L filed Critical Chemo Res S L
Publication of TR201906738T4 publication Critical patent/TR201906738T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A61F6/142—Wirelike structures, e.g. loops, rings, spirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Abstract

Buluş; (a) poliüretan içeren bir çekirdek; (b) etilen vinil asetat içeren bir kılıf, söz konusu kılıf, söz konusu çekirdeği büyük ölçüde veya tamamen çevrelemektedir; ve (c) söz konusu çekirdekte ve/veya söz konusu kılıfta çözünmüş veya dağılmış bir veya daha fazla etken farmasötik içerik maddesi içeren bir cihaz; ve bunun preparasyonuna yönelik bir proses ile ilgilidir.
TR2019/06738T 2012-02-14 2013-02-13 Bir çekirdek ve bir kılıf içeren kontrasepsiyonda kullanıma yönelik ilaç taşıyıcı sistem. TR201906738T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261598642P 2012-02-14 2012-02-14

Publications (1)

Publication Number Publication Date
TR201906738T4 true TR201906738T4 (tr) 2019-05-21

Family

ID=47749791

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/06738T TR201906738T4 (tr) 2012-02-14 2013-02-13 Bir çekirdek ve bir kılıf içeren kontrasepsiyonda kullanıma yönelik ilaç taşıyıcı sistem.

Country Status (17)

Country Link
US (2) US9132081B2 (tr)
EP (3) EP2814458B1 (tr)
AR (1) AR089990A1 (tr)
CY (1) CY1121563T1 (tr)
DK (1) DK2814458T3 (tr)
ES (1) ES2730208T3 (tr)
HR (1) HRP20190716T1 (tr)
HU (1) HUE043105T2 (tr)
LT (1) LT2814458T (tr)
PL (1) PL2814458T3 (tr)
PT (1) PT2814458T (tr)
RS (1) RS58690B1 (tr)
SI (1) SI2814458T1 (tr)
TR (1) TR201906738T4 (tr)
TW (1) TW201332585A (tr)
UY (1) UY34625A (tr)
WO (1) WO2013120888A2 (tr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015044415A1 (en) * 2013-09-30 2015-04-02 Universiteit Gent Polyurethanes as oral drug delivery platform
US10596103B2 (en) 2013-12-11 2020-03-24 Merek Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
BR112018070199A2 (pt) 2016-04-01 2019-01-29 Therapeuticsmd Inc composição farmacêutica de hormônio esteroide
AU2017338924B2 (en) * 2016-10-05 2023-02-16 Titan Pharmaceuticals, Inc. Implantable devices for drug delivery with reduced burst release
EP3395335A1 (en) * 2017-04-24 2018-10-31 Kern Pharma, S.L. Vaginal ring for the simultaneous release of two active ingredients
CN109248139A (zh) * 2017-07-14 2019-01-22 国家卫生计生委科学技术研究所 复方左炔诺孕酮阴道环的制备方法和应用
SG11202005949UA (en) 2018-05-24 2020-07-29 Celanese Eva Performance Polymers Corp Implantable device for sustained release of a macromolecular drug compound
US11690807B2 (en) 2018-05-24 2023-07-04 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
EP4215181A1 (en) 2022-01-21 2023-07-26 Sever Pharma Solutions An intravaginal ring
EP4215180A1 (en) 2022-01-21 2023-07-26 Sever Pharma Solutions A drug delivery system

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
MXPA06010905A (es) 2004-03-24 2007-03-08 Organon Nv Sistema para el suministro de farmacos basados en copolimeros de polietileno y acetato de vinilo.
CA2669066A1 (en) * 2006-11-20 2008-05-29 N.V. Organon Helically-shaped drug delivery system
KR20090110355A (ko) * 2007-01-19 2009-10-21 더 유니버시티 오브 유타 리서치 파운데이션 치료제 전달용 생분해성 질내 기구
EP3391874A3 (en) 2007-02-12 2019-04-24 Particle Sciences, Inc. Delivery devices containing encapsulated and/or particle- bound active pharmaceutical ingredients
EP2244782A4 (en) 2008-01-25 2011-09-14 Univ Utah Res Found POLYMER FOR LINEAR RELEASE
US20100040671A1 (en) 2008-08-12 2010-02-18 Ahmed Salah U Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof
LT2547332T (lt) 2010-03-16 2018-12-10 Titan Pharmaceuticals, Inc. Heterogeninės implantuojamos priemonės, skirtos vaisto pristatymui

Also Published As

Publication number Publication date
HUE043105T2 (hu) 2019-08-28
RS58690B1 (sr) 2019-06-28
US20160000706A1 (en) 2016-01-07
DK2814458T3 (da) 2019-05-13
HRP20190716T1 (hr) 2019-06-14
US9132081B2 (en) 2015-09-15
EP3449909A2 (en) 2019-03-06
LT2814458T (lt) 2019-05-27
EP2814458B1 (en) 2019-04-10
PT2814458T (pt) 2019-05-30
EP4212146A2 (en) 2023-07-19
US20130209539A1 (en) 2013-08-15
EP4212146A3 (en) 2023-09-27
UY34625A (es) 2013-09-02
WO2013120888A3 (en) 2013-10-31
PL2814458T3 (pl) 2019-08-30
WO2013120888A2 (en) 2013-08-22
CY1121563T1 (el) 2020-05-29
EP2814458A2 (en) 2014-12-24
US9872829B2 (en) 2018-01-23
SI2814458T1 (sl) 2019-06-28
ES2730208T3 (es) 2019-11-08
AR089990A1 (es) 2014-10-01
EP3449909A3 (en) 2019-05-29
TW201332585A (zh) 2013-08-16

Similar Documents

Publication Publication Date Title
TR201906738T4 (tr) Bir çekirdek ve bir kılıf içeren kontrasepsiyonda kullanıma yönelik ilaç taşıyıcı sistem.
HK1215666A1 (zh) 藥劑儲存、分配和給藥系統與方法
BR112015009189A2 (pt) conjunto de potência para um autoinjetor e autoinjetor que contém o mesmo
CL2013000718A1 (es) Un complejo de inclusion que comprende a) una ciclodextrina, b) fulvestrant y c) un portador; su metodo de preparacion; formulacion y forma de dosificacion que comprende al complejo; preparacion que comprende al complejo o a la formulación; y su uso en el tratamiento del cancer y lupus eritematoso sistemico, entre otras enfermedades.
EP3072506A4 (en) Carrier for drug delivery and conjugate, composition containing same, and method for administering same
BR112012032008A2 (pt) anticorpos s100a4 e usos terapêuticos do mesmo
MX346596B (es) Oligodesoxinucleotidos inmunoestimuladores.
BR112016006171A2 (pt) formulações de espuma e dispositivo para sua entrega
EA201591830A1 (ru) Фармацевтические композиции, включающие эверолимус
EA201400737A1 (ru) Система доставки на основе множества пеллет с немедленным высвобождением активного вещества
EA201490862A1 (ru) Осмотически активная система вагинальной доставки
CL2016000944A1 (es) Nueva formulación de ganadotropinas
MX2015007731A (es) Formulacion farmaceutica que comprende ciclesonida.
PE20160850A1 (es) Sistema multiparticulado para administrar drogas
TR201007250A2 (tr) Selobioz içeren formülasyon.
EP3064201A4 (en) Pharmaceutical composition for preventing and treating central nervous system diseases containing fluoxetine and vitamin c as active ingredients
丁业宏 Unit 4 Exploring plants
IT1399254B1 (it) Dispositivo per la medicazione emostatica in canali ano-rettali o vaginali.
高鹏骥 De novo malignancies after liver transplantation
张利青 Module 2 Unit4 Using Language Animal Extinction
UA75397U (ru) Способ лечения больных урогенитальным трихомониазом
姜天悦 James, a Clever Fish
翟佩珏 How to Train English Speaking
胡蓉 An Easy Crossword Puzzle
Bhattarai My Experience of 60 Years: Work for Promotion of Nepal-China Relations